Hi-Stim Pre-Workout - Killer Labz Executioner 30 Servings
Need a strong pre-workout to get you through your toughest training sessions? Well look no further than Killer Labz Executioner for all of your workout performance needs! Killer Labz Executioner packs a massive 400mg of caffeine per scoop, and Killer Labz even recommends first-time users start with a half scoop- that's how powerful this pre-workout is.
Killer Labz Executioner Benefits
- Contains a Huge 400mg of Caffeine per Scoop
- Promotes Intense Energy, Motivation, & More
- Boosts Stamina & Endurance
- Promotes Better Mood, Focus, & Alertness
- Promotes Mind-Muscle Connection
- Enhances Blood Flow for Strong Muscle Pumps
Killer Labz Executioner Flavors
- Strawberry Murder-ita
- Sour Slaughter
How to Take Killer Labz Executioner
Killer Labz recommends starting with a 1/2 scoop first to assess tolerance. Mix 1 scoop of Executioner with 6-8 oz. of water and take 20-30 minutes before starting your workout.
Killer Labz Executioner Ingredients
Serving Size: 1 Scoop (11g)
Servings per Container: 30
Amount per Serving %Daily Value*
Killer Pumps & Performance
Beta-Alanine 2500mg **
Betaine Anhydrous 2000mg **
Taurine 1000mg **
Choline Bitartrate 500mg **
S7 (Green coffee bean (fruit) Extract, Green Tea (leaf) Extract, Turmeric (root) extract, Tart Cherry (fruit), Blueberry (fruit), Kale (leaf), Broccoli (whole plant))
Killer Energy & Focus
Caffeine Anhydrous 400mg **
Eria Jarensis (whole plant) Extract 250mg **
Infinergy (DiCaffeine Malate) 100mg **
N-Methyltyramine 50mg **
N-Isopropylnorsynephrine 30mg **
Huperzia Serrata Extract (std. to 1% Huperzine-A) 10mg **
*Percent Daily Values are based on a 2,000 calorie diet.
**Daily Value not established.
Killer Labz Executioner Warnings
Begin with half a serving to assess tolerance. Don't take within 6 hours of bedtime. Store in a cool dry place after opening.
Norager CB, Jensen MB, Weimann A, Madsen MR. Metabolic effects of caffeine ingestion and physical work in 75-year old citizens. A randomized, double-blind, placebo-controlled, cross-over study. Clin Endocrinol (Oxf). 2006 Aug;65(2):223-8. doi: 10.1111/j.1365-2265.2006.02579.x. PMID: 16886964.